Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

BACKGROUND: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Public Health
Main Authors: Ahmed, Mohammad Z., Zia, Qamar, Haque, Anzarul, Alqahtani, Ali S., Almarfadi, Omar M., Banawas, Saeed, Alqahtani, Mohammed S., Ameta, Keshav L., Haque, Shafiul
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871101/
https://ncbi.nlm.nih.gov/pubmed/33866129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.01.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados